214 results on '"Fodde, R."'
Search Results
2. Smad4 haploinsufficiency in mouse models for intestinal cancer
3. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP)
4. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer
5. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree
6. 12 DOC1-dependent recruitment of NURD reveals antagonism with SWI/SNF during epithelial-mesenchymal transition in oral cancer cells
7. ??¢-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis
8. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
9. Identification of gene expression profiling to predict pathologic response of rectal carcinoma after preoperative chemoradiotherapy
10. Prevalence and molecular heterogeneity of alfa+thalassemia in two tribal populations from Andhra Pradesh, India
11. A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis
12. Functional interaction between PKA and BM? Signaling during osteogenic differentiation of human mesenchymal stem cells
13. De moleculaire basis van darmkanker: van gen tot genezing
14. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade
15. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16
16. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis (vol 110, pg 1020, 1996)
17. Use of Aspirin postdiagnosis improves survival for colon cancer patients
18. 7 NEW MUTATIONS IN HMSH2, AN HNPCC GENE, IDENTIFIED BY DENATURING GRADIENT-GEL ELECTROPHORESIS
19. MAPPING OF 2 NEW MARKERS WITHIN THE SMALLEST INTERVAL HARBORING THE SPINAL MUSCULAR-ATROPHY LOCUS BY FAMILY AND RADIATION HYBRID ANALYSIS
20. A new conditional Apc-mutant mouse model for colorectal cancer
21. Tumour–stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness
22. Of mice and (wo)men: genotype-phenotype correlations in BRCA1
23. Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis
24. Embryonic lethality in the Brca1-1700T mouse model suggests inhibition of p53-dependent pathways
25. FAP and Marfanoid habitus
26. Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development
27. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.
28. Rapid detection of the highly polymorphic beta globin framework by denaturing gradient gel electrophoresis.
29. Homozygous beta+ thalassaemia owing to a mutation in the cleavage-polyadenylation sequence of the human beta globin gene.
30. Interaction of two different disorders in the beta-globin gene cluster associated with an increased hemoglobin F production: a novel deletion type of (G) gamma + ((A) gamma delta beta)(0)-thalassemia and a delta(0)-hereditary persistence of fetal hemoglobin determinant
31. Multiple recombination events are responsible for the heterogeneity of ?+-thalassemia haplotypes among the forest tribes of Andhra Pradesh, India
32. AT repeat polymorphism at the D5S122 locus tightly linked to adenomatous polyposis coli (APC)
33. CA repeat polymorphism at the D5S82 locus, proximal to adenomatous polyposis coli (APC)
34. CA repeat polymorphism at the D5S299 locus linked to adenomatous polyposis coli (APC)
35. CA repeat polymorphism within the MCC (mutated in colorectal cancer) gene
36. CA repeat polymorphism from YAC JW25 at the D5S318 locus, distal to adenomatous polyposis coli (APC)
37. Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness.
38. A new Avall RFLP in the human α-globin gene cluster
39. Evidence forMsh2haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis.
40. Molecular epidemiology and cancer prevention. Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months.
41. Intestinal and extra-intestinal tumor multiplicities in the Apc1638N mouse model after exposure to X-rays.
42. Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in Apc1638N transgenic mice.
43. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis.
44. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance
45. E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice
46. Molecular epidemiology and cancer prevention. Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months
47. Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months.
48. Apc1638N: A mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts
49. Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in Apc1638N transgenic mice.
50. Familial adenomatous polyposis associated with multiple adrenal adenomas in a patient with a rare 3′ APC mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.